跳至主要内容
临床试验/NCT06446895
NCT06446895招募中不适用

Biomarkers of Inflammation and Endothelial Dysfunction in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries

Hospital Universitario Getafe1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400
试验地点
1
主要终点
Levels of endhotelial disfunction biomarkers

研究概览

简要总结

Around 10% of patients with myocardial infarction (MI) present with nonobstructive coronary arteries (MINOCA) which pathophysiology is often uncertain. The aim of the study is to evaluate inflammation and endothelial dysfunction biomarkers in MINOCA patients during both acute and stable phases, comparing them with those with MI and obstructive coronary arteries (MICAD).

详细描述

Prospective observational study in patients with Myocardial Infarction (MI) divided into two groups: MI with obstructive coronary arteries (MICAD) and MI with non-obstructive coronary arteries (MINOCA). Levels of interleukin-6, tumor necrosis factor-alpha, high-sensitivity C- reactive protein, and asymmetric dimethylarginine will be determined at three time points: within the 24 hours from the onset of pain, discharge, and two months after MI. The association of biomarkers, normalized by peak troponin value, with the risk of MINOCA will be evaluated using logistic regression.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted with Myocardial Infarction and undergo a coronariography
  • Patients must sign informed consent.

排除标准

  • Patients who don´t sign informed consent

结局指标

主要结局

Levels of endhotelial disfunction biomarkers

时间窗: At three time points: within the 24 hours from the onset of pain, on the 5th day of admission, and two months after MI.

Levels of asymmetric dimethylarginine will be determined

Levels of high-sensitivity C-reactive protein (mg/L)

时间窗: t three time points: within the 24 hours from the onset of pain, on the 5th day of admission, and two months after MI.

Levels of high-sensitivity C-reactive protein (mg/L) will be determined.

Levels of interleukin-6 (pg/ml) and tumor necrosis factor-alpha (pg/ml)

时间窗: At three time points: within the 24 hours from the onset of pain, on the 5th day of admission, and two months after MI.

Levels of interleukin-6 (pg/ml) and tumor necrosis factor-alpha (pg/ml) will be determined.

次要结局

未报告次要终点

研究者

发起方
Hospital Universitario Getafe
申办方类型
Other
责任方
Principal Investigator
主要研究者

maria jesus espinosa pascual

Cardiologist

Hospital Universitario Getafe

研究点 (1)

Loading locations...

相似试验